Fulcrum Therapeutics (FULC) Other Non Operating Income (2018 - 2019)
Fulcrum Therapeutics (FULC) reported Other Non Operating Income of $7000.0 for Q4 2019, little changed year-over-year from $7000.0 in Q4 2018, and little changed quarter-over-quarter from $7000.0 in Q3 2019.
Fulcrum Therapeutics (FULC) Other Non Operating Income (2018 - 2019) Analysis & Trends
Fulcrum Therapeutics (FULC) has 2 years of Other Non Operating Income data on file, last reported at $7000.0 in Q4 2019.
- Other Non Operating Income for Q4 2019 came in at $7000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2019 was $29000.0 (changed N/A YoY), and the FY2019 annual result was $29000.0, down 92.6% from the prior year.
- Other Non Operating Income was little changed at $7000.0 in Q4 2019 per FULC's latest filing, from $7000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $8000.0 in Q2 2018 and troughed at $7000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Fulcrum Therapeutics | 267.90 Mn | 267.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 7,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 8,000.00 |
| Dec 31, 2018 | 7,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Jun 30, 2018 | 8,000.00 |